Literature DB >> 18810564

Changes of the metabolism of the colon cancer cell line SW-480 under serum-free and serum-reduced growth conditions.

Michelle Hartmann1, Dunja Zimmermann, Jürgen Nolte.   

Abstract

Serum of animal origin, like foetal calf serum (FCS), is used as a standard supplement for media to cultivate mammalian cells, mostly due to its growth-supporting properties. Unfortunately, animal serum has many disadvantages like the risk of contamination, high costs, fluctuations within the composition of different batches and the high amount of foetuses, which have to be harvested. To avoid all this, it is necessary to provide alternatives, which combine as many positive properties of the animal serum as possible but do not influence the cellular metabolism negatively. Today, several serum-free complete media as well as serum substitutes are commercially available. In the present study, a serum substitute, a serum-reduced medium and a serum-free medium were evaluated concerning their influence on the metabolism on the colon cancer cell line SW-480. The evaluation of morphological changes of the cells was done by microscopic analysis whereas differences in the volatile metabolome were analysed by solid phase micro extraction (SPME) followed by gas chromatography/mass spectrometry (GC/MS).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810564     DOI: 10.1007/s11626-008-9133-x

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  8 in total

1.  Alternatives to the use of fetal bovine serum: serum-free cell culture.

Authors:  Gerhard Gstraunthaler
Journal:  ALTEX       Date:  2003       Impact factor: 6.043

2.  Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells.

Authors:  Frank Wolf; Cornelia Wandke; Nina Isenberg; Stephan Geley
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

3.  Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.

Authors:  S Jiang; M J Song; E C Shin; M O Lee; S J Kim; J H Park
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

Review 4.  To treat or not to treat: that is the question for serum.

Authors:  J Hodgson
Journal:  Biotechnology (N Y)       Date:  1995-04

Review 5.  Development and advantages of serum-free, chemically defined nutrient media for culturing of nerve tissue.

Authors:  H J Romijn
Journal:  Biol Cell       Date:  1988       Impact factor: 4.458

6.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

7.  The use of fetal bovine serum: ethical or scientific problem?

Authors:  Carlo E A Jochems; Jan B F van der Valk; Frans R Stafleu; Vera Baumans
Journal:  Altern Lab Anim       Date:  2002 Mar-Apr       Impact factor: 1.303

8.  Meeting report: alternatives for developmental neurotoxicity testing.

Authors:  Pamela Lein; Paul Locke; Alan Goldberg
Journal:  Environ Health Perspect       Date:  2007-01-29       Impact factor: 9.031

  8 in total
  4 in total

Review 1.  Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.

Authors:  Kamila Schmidt; Ian Podmore
Journal:  J Biomark       Date:  2015-03-30

2.  Systematic evaluation of sericin protein as a substitute for fetal bovine serum in cell culture.

Authors:  Liyuan Liu; Jinhuan Wang; Shengchang Duan; Lei Chen; Hui Xiang; Yang Dong; Wen Wang
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

3.  Silk Sericin Hydrolysate is a Potential Candidate as a Serum-Substitute in the Culture of Chinese Hamster Ovary and Henrietta Lacks Cells.

Authors:  Meng Zhang; Ting-Ting Cao; Zheng-Guo Wei; Yu-Qing Zhang
Journal:  J Insect Sci       Date:  2019-01-01       Impact factor: 1.857

4.  CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile.

Authors:  Zangiacomi Vincent; Kenichi Urakami; Koji Maruyama; Ken Yamaguchi; Masatoshi Kusuhara
Journal:  Genes Cancer       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.